{
  "actions": [
    {
      "acted_at": "2016-09-14", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-09-14", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6033-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "bioguide_id": "B001296", 
      "district": "13", 
      "name": "Boyle, Brendan F.", 
      "original_cosponsor": true, 
      "sponsored_at": "2016-09-14", 
      "state": "PA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "R000598", 
      "district": "12", 
      "name": "Rothfus, Keith J.", 
      "original_cosponsor": true, 
      "sponsored_at": "2016-09-14", 
      "state": "PA", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-09-14", 
  "number": "6033", 
  "official_title": "To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act", 
  "sponsor": {
    "bioguide_id": "P000608", 
    "district": "52", 
    "name": "Peters, Scott H.", 
    "state": "CA", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-09-14", 
  "subjects": [
    "Cardiovascular and respiratory health", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Health", 
    "Infectious and parasitic diseases"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2016-09-14T04:00:00Z", 
    "text": "Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act\n\nThis bill amends the Federal Food, Drug, and Cosmetic Act to add Middle East respiratory syndrome to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)"
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2018-11-21T21:23:45Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/114/hr/BILLSTATUS-114hr6033.xml"
}